Topotecan HCl
Topotecan HCl is the first topoisomerase I-directed cytotoxic agent to enter clinical trials in the United States.
| Trivial name | NSC 609699; SKFS-104864A; SK&F104864-A |
| Catalog Number | CSN12236 |
| Alternative Name(s) | NSC 609699; SKFS-104864A; SK&F104864-A |
| Research Area | Cancer |
| Molecular Formula | C23H24ClN3O5 |
| CAS# | 119413-54-6 |
| Purity | ≥99% |
| SMILES | O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=CC5=C(CN(C)C)C(O)=CC=C5N=C4C3=C2)=O.[H]Cl |
| Size | 50mg |
| Supplier Page | https://www.csnpharm.com/products/topotecan-hcl.html |